Metaproteogenomic analysis of saliva samples from Parkinson’s disease patients with cognitive impairment

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
Metaproteogenomic analysis of saliva samples from Parkinson’s disease patients with cognitive impairment ; volume:9 ; number:1 ; day:18 ; month:11 ; year:2023 ; pages:1-10 ; date:12.2023
npj Biofilms and Microbiomes ; 9, Heft 1 (18.11.2023), 1-10, 12.2023

Urheber
Arıkan, Muzaffer
Demir, Tuğçe Kahraman
Yıldız, Zeynep
Nalbantoğlu, Özkan Ufuk
Korkmaz, Nur Damla
Yılmaz, Nesrin H.
Şen, Aysu
Özcan, Mutlu
Muth, Thilo
Hanoğlu, Lütfü
Yıldırım, Süleyman
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1038/s41522-023-00452-x
URN
urn:nbn:de:101:1-2024013114254357551420
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:33 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Arıkan, Muzaffer
  • Demir, Tuğçe Kahraman
  • Yıldız, Zeynep
  • Nalbantoğlu, Özkan Ufuk
  • Korkmaz, Nur Damla
  • Yılmaz, Nesrin H.
  • Şen, Aysu
  • Özcan, Mutlu
  • Muth, Thilo
  • Hanoğlu, Lütfü
  • Yıldırım, Süleyman
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Metaproteogenomic analysis of saliva samples from Parkinson's disease patients with cognitive impairment

Metaproteogenomic analysis of saliva samples from Parkinson's disease patients with cognitive impairment

Advanced brain aging in Parkinson’s disease with cognitive impairment

Advanced brain aging in Parkinson’s disease with cognitive impairment

Resting-state EEG measures cognitive impairment in Parkinson’s disease

Resting-state EEG measures cognitive impairment in Parkinson’s disease

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?

Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease

Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease

Paeoniflorin ameliorates cognitive impairment in Parkinson’s disease via JNK/p53 signaling

Paeoniflorin ameliorates cognitive impairment in Parkinson’s disease via JNK/p53 signaling

Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study

Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study

Theory of mind in mild cognitive impairment and Parkinson’s disease: The role of memory impairment

Theory of mind in mild cognitive impairment and Parkinson’s disease: The role of memory impairment

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease

Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease

Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease

Cognitive reorganization in patients with Parkinson’s Disease and Mild Cognitive Impairment: a neuropsychological network approach

Cognitive reorganization in patients with Parkinson’s Disease and Mild Cognitive Impairment: a neuropsychological network approach

Verbundene Objekte